Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Oncologist|November 21, 2020
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study DesignJeffrey S Ross, Ethan S Sokol, Holger Moch, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 20, 2014
Quantification of circulating endothelial cells as a predictor of response to chemotherapy with platinum and pemetrexed in patients with advanced non-squamous non-small cell lung carcinomaAlfredo Sánchez Hernández, Oscar José Juan, José Vidal Martínez, et al.
BMC Cancer|May 1, 2015
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI studyPilar Garcia-Alfonso, Manuel Chaves, Andrés Muñoz, et al.
The Oncologist|March 9, 2021
A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial ExperienceChantal Pauli, Tilmann Bochtler, Linda Mileshkin, et al.
Plos One|January 21, 2015
Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancerJaime Feliu, Antonieta Salud, Maria J Safont, et al.
BMC Cancer|April 18, 2015
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancerMargarita García, Mercedes Martinez-Villacampa, Cristina Santos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 3, 2025
SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2025)Maria José Safont Aguilera, Ferran Losa Gaspá, Encarna González-Flores, et al.
BMC Cancer|April 18, 2015
A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological featuresRamon Salazar, Jaume Capdevila, Berta Laquente, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2005
Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancerMiquel Nogué, Antonieta Salud, Eduard Batiste-Alentorn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 TrialJoana Vidal, David Casadevall, Beatriz Bellosillo, et al.
Pageof 3